Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products

  05 March 2021

This reflection paper considers the impact(s) on ecosystems, animal and human health from the presence of antimicrobial residues (ARs) and/or antimicrobial resistance genes (ARGs; a DNA region within the microbial genome that encodes for reduced sensitivity against specific antimicrobials) in the environment resulting from the use of veterinary medicinal products (VMPs). At the outset, we define antimicrobial resistance (AMR) as the ability of microorganisms such as bacteria to become increasingly resistant to an antimicrobial to which they were previously susceptible.

This paper reflects on what is required to address the data gaps and to better understand the factors that influence resistance emergence in the environment such as, movement of ARs and ARGs between different environmental compartments.

Further reading: European Medicines Agency
Author(s): Committee for Medicinal Products for Veterinary Use (CVMP)
Clean Environment   Healthy Animals  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!